Artificial Neural Network Directed Therapy of Severe Obstructive Sleep Apnea
Status and phase
Conditions
Treatments
Details and patient eligibility
About
The investigators have developed a simple, accurate, and a point-of-care, computer-based clinical decision support system (CDSS) not only to detect the presence of sleep apnea but also to predict its severity. The CDSS is based on deploying an artificial neural network (ANN) derived from anthropomorphic and clinical characteristics.
The investigators hypothesize that patients with severe OSA defined as AHI≥30 can be diagnosed with the use of ANN without undergoing a sleep study, and that empiric management with auto-CPAP has similar outcomes to those who undergo a formal sleep study.
Sex
Ages
Volunteers
Inclusion criteria
- Must be an adult (≥18 years old)
- Must have symptoms suggestive of OSA, and be considered for sleep study by the sleep specialist provider.
Exclusion criteria
- Pregnancy or breast feeding
- Patients with severe congestive heart failure (eg, NYHA Class IV, ejection fraction < 35%).
- Patients with end-stage renal disease on hemodialysis
- Patients with CVA, Parkinson, neuromuscular degenerative disease.
- Patient on narcotics.
- Patients with severe lung disease requiring oxygen at night and/or during the day.
- Patient with predominant insomnia or sleep hygiene problems, and who are not considered for PSG by the sleep specialist.
Trial design
Primary purpose
Allocation
Interventional model
Masking
0 participants in 2 patient groups
Trial contacts and locations
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal